Barateau L, Pizza F, Chenini S, Peter-Derex L, Dauvilliers Y. Narcolepsies, update in 2023. Rev Neurol (Paris). 2023;179(7):727–40. https://doi.org/10.1016/j.neurol.2023.08.001.

Article  CAS  PubMed  Google Scholar 

Thorpy MJ, Krahn L, Ruoff C, Foldvary-Schaefer N. Clinical considerations in the treatment of idiopathic hypersomnia. Sleep Med. 2024;119:488–98. https://doi.org/10.1016/j.sleep.2024.05.013.

Article  PubMed  Google Scholar 

Maski K, Trotti LM, Kotagal S, Auger RR, Swick TJ, Rowley JA, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(9):1895–945. https://doi.org/10.5664/jcsm.9326.

Article  PubMed  PubMed Central  Google Scholar 

Trotti LM, Becker LA, Friederich Murray C, Hoque R. Medications for daytime sleepiness in individuals with idiopathic hypersomnia. Cochrane Database Syst Rev. 2021;5:CD012714. https://doi.org/10.1002/14651858.CD012714.pub2.

Maski K, Trotti LM, Kotagal S, Auger RR, Rowley JA, D. HS, et al. Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline Journal of Clinical Sleep Medicine. 2021;17(9):1881-93. https://doi.org/10.5664/jcsm.9328.

Chien PY, Kuo CY, Lin MH, Chang YJ, Hung CC. Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis. J Clin Med. 2022;11(21). https://doi.org/10.3390/jcm11216302.

Zhan S, Ye H, Li N, Zhang Y, Cheng Y, Wang Y, et al. Comparative efficacy and safety of multiple wake-promoting agents for the treatment of excessive daytime sleepiness in narcolepsy: a network meta-analysis. Nat Sci Sleep. 2023;15:217–30. https://doi.org/10.2147/NSS.S404113.

Article  PubMed  PubMed Central  Google Scholar 

Derogatis LR. Symptom Checklist-90-R: Administration, Scoring, and Procedures Manual. Bloomington, IN: NCS Pearson; 1994.

International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

Urbaniak GC, Plous S. Research Randomizer (Version 4.0) [Computer software].

Kaplan KA, Plante DT, Cook JD, Harvey AG. Development and validation of the Hypersomnia Severity Index (HSI): a measure to assess hypersomnia severity and impairment in psychiatric disorders. Psychiatry Res. 2019;281: 112547. https://doi.org/10.1016/j.psychres.2019.112547.

Article  PubMed  PubMed Central  Google Scholar 

Kanady JC, Harvey AG. Development and validation of the sleep inertia questionnaire (SIQ) and assessment of sleep inertia in analogue and clinical depression. Cogn Ther Res. 2015;39(5):601–12. https://doi.org/10.1007/s10608-015-9686-4.

Article  Google Scholar 

Guy W. ECDEU assessment manual for psychopharmacology (DHEW Publication No. ADM 76-338). Washington, D.C.: U.S. Governmenta Printing Office; 1976 1976.

Rosenberg RP, Bogan RK, Tiller JM, Yang R, Youakim JM, Earl CQ, et al. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc. 2010;85(7):630–8. https://doi.org/10.4065/mcp.2009.0778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y. Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Clinical therapeutics. 2016;38(1):162-79 e6. https://doi.org/10.1016/j.clinthera.2015.10.010.

Scrima L, Emsellem HA, Becker PM, Ruoff C, Lankford A, Bream G, et al. Identifying Clinically Important Difference on the Epworth Sleepiness Scale: Results from a Narcolepsy Clinical Trial of JZP-110. Sleep Medicine. 2017;epub ahead of print. https://doi.org/10.1016/j.sleep.2017.07.006.

Maund E, Guski LS, Gotzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ. 2017;189(5):E194–203. https://doi.org/10.1503/cmaj.151104.

Article  PubMed  PubMed Central  Google Scholar 

Wiffen PJ, Derry S, Bell RF, Rice AS, Tolle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938. https://doi.org/10.1002/14651858.CD007938.pub4.

Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25.

Article  CAS  PubMed  Google Scholar 

Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci. 2013;331(1–2):102–7. https://doi.org/10.1016/j.jns.2013.05.023.

Article  CAS  PubMed  Google Scholar 

Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97–110.

CAS  PubMed  Google Scholar 

Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20(10):835–43.

CAS  PubMed  Google Scholar 

Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology. 2013;12(11):1068–75.

Article  CAS  PubMed  Google Scholar 

Ohayon MM, Thorpy MJ, Carls G, Black J, Cisternas M, Pasta DJ, et al. The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis. Sleep Med. 2021;84:405–14. https://doi.org/10.1016/j.sleep.2021.06.008.

Article  PubMed  Google Scholar 

The Voice of the Patient: Narcolepsy. 2014.

Trotti LM, Ong JC, Plante DT, Friederich Murray C, King R, Bliwise DL. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry. Sleep Med. 2020;75:343–9. https://doi.org/10.1016/j.sleep.2020.08.034.

Article  PubMed  PubMed Central  Google Scholar 

International Classification of Sleep Disorders, 3rd edition, text revision (ICSD-3-TR). Darien, IL: American Academy of Sleep Medicine; 2023.

Barateau L, Chenini S, Denis C, Lorber Q, Beziat S, Jaussent I, et al. Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2. Sleep. 2024. https://doi.org/10.1093/sleep/zsad323.

Article  PubMed  Google Scholar 

Trotti LM. Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness. Sleep Med Rev. 2016. https://doi.org/10.1016/j.smrv.2016.08.005.

Article  PubMed  PubMed Central  Google Scholar 

Dauvilliers Y, Evangelista E, Barateau L, Lopez R, Chenini S, Delbos C, et al. Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale. Neurology. 2019;92(15):e1754–62. https://doi.org/10.1212/WNL.0000000000007264.

Article  PubMed  Google Scholar 

Evangelista E, Rassu AL, Lopez R, Biagioli N, Chenini S, Barateau L, et al. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia. Sleep. 2022;45(1). https://doi.org/10.1093/sleep/zsab220.

Trotti LM, Saini P, Bremer E, Mariano C, Moron D, Rye DB, et al. The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence. J Clin Sleep Med. 2022;18(5):1395–403. https://doi.org/10.5664/jcsm.9884.

Article  PubMed  PubMed Central  Google Scholar 

Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Sonka K, Thorpy MJ, et al. Efficacy and Safety of Lower-Sodium Oxybate in Adults With Idiopathic Hypersomnia: A Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study. Lancet Neurol. 2022.

Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time-a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74–81. https://doi.org/10.1111/jsr.12201.

Article  PubMed  Google Scholar 

Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Med. 2021;80:315–21. https://doi.org/10.1016/j.sleep.2021.01.018.

Article  PubMed  Google Scholar 

Sonka K, Susta M, M. B. Narcolepsy with and without cataplexy, idiopathc hypersomnia with and without long sleep time: a cluster analysis. Sleep Medicine. 2015;epub ahead of print. https://doi.org/10.1016/j.sleep.2014.09.016.

Trotti LM, Staab BA, Rye DB. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med. 2013;9(8):789–95. https://doi.org/10.5664/jcsm.2922.

Article  PubMed  PubMed Central  Google Scholar 

Ruoff C, Pizza F, Trotti LM, Sonka K, Vandi S, Cheung J, et al. The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study. J Clin Sleep Med. 2017.

Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, et al. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep. 2017;40(12). https://doi.org/10.1093/sleep/zsx164.

Fronczek R, Arnulf I, Baumann CR, Maski K, Pizza F, Trotti LM. To Split or to Lump? Classifying the Central Disorders of Hypersomnolence. Sleep. 2020. https://doi.org/10.1093/sleep/zsaa044.

Article  PubMed  PubMed Central  Google Scholar